437
Views
28
CrossRef citations to date
0
Altmetric
Drug Safety Evaluation

Long-term treatment with infliximab in inflammatory bowel disease: safety and tolerability issues

, MD PhD, , MD & , MD PhD
Pages 617-632 | Published online: 01 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Vera Kandror Denmark & Lloyd Mayer. (2013) Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease: an update. Expert Review of Clinical Immunology 9:1, pages 77-92.
Read now
Brijen Shah & Lloyd Mayer. (2010) Current status of monoclonal antibody therapy for the treatment of inflammatory bowel disease. Expert Review of Clinical Immunology 6:4, pages 607-620.
Read now
Emma J Eshuis, Willem A Bemelman & Pieter CF Stokkers. (2009) Infliximab for the treatment of ulcerative colitis. Expert Review of Gastroenterology & Hepatology 3:3, pages 219-229.
Read now

Articles from other publishers (25)

Cassandre Djian, Karine Champion, Nicolas Lai, Ludovic Drouet, Blanca Amador Borrero, Audrey Depond, Stéphane Mouly, Clément Jourdaine, Philippe Herman, Michael Eliezer, Charlotte Hautefort & Damien Sène. (2023) Infliximab for the Treatment of Inflammatory Labyrinthitis: A Retrospective Cohort Study. Journal of Clinical Medicine 12:13, pages 4350.
Crossref
Haifeng Jin, Jie Guo, Jiemin Liu, Bin Lyu, Robert D. Foreman, Zhaohong Shi, Jieyun Yin & Jiande D. Z. Chen. (2019) Autonomically mediated anti‐inflammatory effects of electrical stimulation at acupoints in a rodent model of colonic inflammation. Neurogastroenterology & Motility 31:8.
Crossref
Lukas Delasos, Aakash Desai, Nerea Lopetegui Lia, Nikhila Kethireddy & Carolyn Ray. (2019) A Case of Immunotherapy-Induced Colitis Complicated by Perforation and Treated with Infliximab Postoperatively. Case Reports in Oncological Medicine 2019, pages 1-6.
Crossref
I. G. Kirillova, D. S. Novikova, T. V. Popkova, E. V. Udachkina, E. I. Markelova, A. A. Novikov, Yu. N. Gorbunova, A. V. Volkov, E. L. Luchikhina, N. V. Demidova, M. A. Borisova & G. V. Lukina. (2018) IMPACT OF ANTIRHEUMATIC THERAPY ON THE LEVEL OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS. Rheumatology Science and Practice 56:3, pages 328-332.
Crossref
I V Maev, A N Kazulin & D N Andreev. (2018) The cardiovascular system in patients with functional and inflammatory bowel diseases. Terapevticheskii arkhiv 90:2, pages 59-64.
Crossref
Haifeng JinJie Guo, Jiemin LiuBin LyuRobert D. ForemanJieyun Yin, Zhaohong Shi & Jiande D. Z. Chen. (2017) Anti-inflammatory effects and mechanisms of vagal nerve stimulation combined with electroacupuncture in a rodent model of TNBS-induced colitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 313:3, pages G192-G202.
Crossref
Edward V. LoftusJr.Jr., Jean-Frederic Colombel, Stefan Schreiber, Charles W. Randall, Miguel Regueiro, Tauseef Ali, Catherine Arendt, Jason Coarse, Marshall Spearman & Gordana Kosutic. (2016) Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of?Data From Clinical Trials. Clinical Gastroenterology and Hepatology 14:12, pages 1753-1762.
Crossref
Jason P. Gordon, Phil C. McEwan, Andy Maguire, Daniel M. Sugrue & Jorge Puelles. (2015) Characterizing unmet medical need and the potential role of new biologic treatment options in patients with ulcerative colitis and Crohn’s disease. European Journal of Gastroenterology & Hepatology 27:7, pages 804-812.
Crossref
Angela Sena, Irina Grishina, Anne Thai, Larissa Goulart, Monica Macal, Anne Fenton, Jay Li, Thomas Prindiville, Sonia Maria Oliani, Satya Dandekar, Luiz Goulart & Sumathi Sankaran-Walters. (2013) Dysregulation of Anti-Inflammatory Annexin A1 Expression in Progressive Crohns Disease. PLoS ONE 8:10, pages e76969.
Crossref
Ľubomír Tomáš, Ivica Lazúrová, Lýdia Pundová, Mária Oetterová, Mária Zakuciová, Darina Petrášová & Martin Studenčan. (2012) Acute and long-term effect of infliximab on humoral and echocardiographic parameters in patients with chronic inflammatory diseases. Clinical Rheumatology 32:1, pages 61-66.
Crossref
Xue Ting Wee, Yvonne Koh & Chun Wei Yap. (2012) Automated systems to identify relevant documents in product risk management. BMC Medical Informatics and Decision Making 12:1.
Crossref
Yuichiro Yamashiro, Jennifer Martin, Madlen Gazarian, Sharon Kling, Hidefumi Nakamura, Akira Matsui, Salvatore Cucchiara, Marina Aloi, Erica L. Wynn & Andrew E. Mulberg. (2012) Drug Development. Journal of Pediatric Gastroenterology & Nutrition 55:5, pages 506-510.
Crossref
Atul Bagul. (2012) Ischaemic/reperfusion injury: Role of infliximab. World Journal of Transplantation 2:3, pages 35.
Crossref
Sumathi Sankaran-Walters, Kanat Ransibrahmanakul, Irina Grishina, Jason Hung, Enrique Martinez, Thomas Prindiville & Satya Dandekar. (2011) Epstein–Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease. Journal of Clinical Virology 50:1, pages 31-36.
Crossref
Fernando Magro & Francisco Portela. (2010) Management of Inflammatory Bowel Disease with Infliximab and Other Anti-Tumor Necrosis Factor Alpha Therapies. BioDrugs 24, pages 3-14.
Crossref
Sally de Boer & Margaret Wilsher. (2010) Review Series: Aspects of Interstitial lung disease: Sarcoidosis. Chronic Respiratory Disease 7:4, pages 247-258.
Crossref
Mario Curione, Annalisa Aratari, Silvia Amato, Marco Colotto, Maria Barbato, Silvia Leone, Andi Tego, Diego Panetti & Claudio Parlapiano. (2010) A study on QT interval in patients affected with inflammatory bowel disease without cardiac involvement. Internal and Emergency Medicine 5:4, pages 307-310.
Crossref
Kerstin Gronbach, Ute Eberle, Martina Müller, Tobias A. Ölschläger, Ulrich Dobrindt, Frank Leithäuser, Jan Hendrik Niess, Gerd Döring, Jörg Reimann, Ingo B. Autenrieth & Julia-Stefanie Frick. (2010) Safety of Probiotic Escherichia coli Strain Nissle 1917 Depends on Intestinal Microbiota and Adaptive Immunity of the Host . Infection and Immunity 78:7, pages 3036-3046.
Crossref
Balamurugan Ramadass, Sucharita Chittaranjan, Venkataraman Subramanian & Balakrishnan S. Ramakrishna. (2010) Fecal polymerase chain reaction for Mycobacterium tuberculosis IS6110 to distinguish Crohn’s disease from intestinal tuberculosis. Indian Journal of Gastroenterology 29:4, pages 152-156.
Crossref
Elena Chiappini, Maurizio de Martino, Franscesca Mangiantini & Paolo Lionetti. (2009) Crohn Disease and Mycobacterial Infection in Children: An Intriguing Relationship. Journal of Pediatric Gastroenterology & Nutrition 49:5, pages 550-558.
Crossref
Michael P. Pollastri, Adrian Whitty, Jamie Cassidy Merrill, Xiaoren Tang, Trent D. Ashton & Salomon Amar. (2009) Identification and Characterization of Kava-derived Compounds Mediating TNF- α Suppression . Chemical Biology & Drug Design 74:2, pages 121-128.
Crossref
Åsa C.M. Johansson, Kutty S. Nandakumar, Ann-Maj Persson, Inge Olsson & Markus Hansson. (2009) Secretory lysosome targeting and induced secretion of human soluble TNF-α receptor in murine hematopoietic cells in vivo as a principle for immunoregulation in inflammation and malignancy. Experimental Hematology 37:8, pages 969-978.
Crossref
Gema de la Poza G?mez, Antonio L?pez-San Rom?n, Jaime Masjuan Vallejo, Gemma Arranz de la Mata, Teresa Angueira Lape?a & Daniel Boixeda de Miquel. (2009) Colitis ulcerosa asociada a enfermedad de Vogt-Koyanagi-Harada. Gastroenterolog?a y Hepatolog?a 32:5, pages 343-345.
Crossref
Richard Stratton, Gabrielle Slapak, Tabitha Mahungu & Sabine Kinloch-de Loes. (2009) Autoimmunity and HIV. Current Opinion in Infectious Diseases 22:1, pages 49-56.
Crossref
Lauren Martz. (2009) Boosting hedgehog against IBD. Science-Business eXchange 2:2, pages 38-38.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.